Novo Holdings closes $16.5 billion buyout of contract manufacturer Catalent
(Reuters) - Novo Holdings, the controlling shareholder of Novo Nordisk (NYSE:NVO), on Wednesday sealed its $16.5 billion deal for Catalent (NYSE:CTLT), as the Danish drugmaker...